Brasília – Anvisa participates in the meetings of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) and the International Pharmaceutical Regulators Programme (IPRP), held between 15 and 20 November in Singapore. The Brazilian delegation took part in the ICH Assembly, the Steering Committee and several working groups, including M7 Subgroup, M13, M18, Q1, Q6(R1), E21 and E23, as well as the IPRP Steering Committee.

According to the agency, the participation reinforces Brazil’s engagement in international regulatory convergence initiatives, contributing to the alignment of standards on quality, safety and efficacy of medicines. The meetings also included the incorporation of the Dominican Republic’s Dirección General de Medicamentos, Alimentos y Productos Sanitarios as a new ICH observer.

Source: Anvisa